On May 14, 2024, Blake Borgeson, Director at Recursion Pharmaceuticals Inc (NASDAQ:RXRX), executed a sale of 20,054 shares of the company.
On May 15, 2024, Charles Pacala, President and Chief Executive Officer of Ouster Inc (NYSE:OUST), purchased 16,000 shares of the company.
On May 15, 2024, Director Virginia Boulet of Ouster Inc (NYSE:OUST) purchased 10,000 shares of the company, as reported in a recent SEC Filing.
Thru | Total | ||
---|---|---|---|
F | -9 | ||
F | -6 | ||
F | -6 | ||
F | -6 | ||
F | -5 | ||
F | -5 | ||
F | -5 | ||
F | -5 | ||
F | -5 | ||
F | -5 |